天美传媒

Skip to content
Health & Medicine

Student work earns national praise in data science competition

A data science project to help clinicians predict Parkinson鈥檚 disease progression landed two 天美传媒 undergraduates and their faculty mentor a top spot in a prestigious data science contest.

Unlocking big data

A Newscenter series on how Rochester is using data science to change how we research, how we learn, and how we understand our world.

Sam Lerman 鈥�17, a dual computer science and mathematics major, and Nick Potter 鈥�17, a mathematics major, led the project in collaboration with Charles Venuto, an assistant professor of neurology at the Medical Center鈥檚 . The team entered their computer model in a data challenge organized by the Michael J. Fox Foundation and GE Healthcare. Competing against other data and computational scientists, the students learned their submission was one of the top three finalists in determining baseline factors predictive of clinical disease progression in Parkinson鈥檚 disease patients.

鈥淭his is quite the impressive accomplishment for our students and research,鈥� Venuto says. 鈥淚dentifying disease progression in Parkinson鈥檚 disease has been a real challenge. Right now, clinicians lack objective means to provide Parkinson鈥檚 disease patients advice on what to expect the symptomatic course of their disease will be in the next six months, in the next year, and so on.鈥�

Parkinson鈥檚 disease is a nervous system disorder that affects movement, with symptoms worsening over time. Age of onset, rate of disease progression, and type and severity of symptoms vary for the five million people worldwide living with the disease.

Generating algorithms and models for prognosis would aid in patient care and planning clinical trials.

The Parkinson鈥檚 Progression Markers Initiative (PPMI) provided contest participants with a dataset of baseline information from a group of patients. The challenge involved analyzing this dataset to gain new insight into diagnosis and disease progression.

graphic illustration a patient's individualized timeline over 24 months
(University image / Sam Lerman, Nick Potter, Charles Venuto)

鈥淔irst we asked, 鈥楬ow is 颅颅颅颅颅disease progression quantified?鈥欌�� Lerman says. 鈥淥nce we defined our target, then we worked on developing and building models.鈥�

Lerman, Potter, and Venuto鈥檚 submission included machine learning algorithms they developed to predict three things:

  • Rate of progression: Will patients have fast, moderate, or slow disease progression?
  • Time until symptom onset: How long, in months, will it take for a patient to exhibit tremors or bradykinesia鈥攁 symptom characterized by slowness of movement?
  • Future score on disease scales: How will a patient fare on the Unified Parkinson鈥檚 Disease Rating Scale (UPDRS), a rating tool to measure disease progression through analysis of mood, behavior, activities of daily living, and motor skills?

鈥淭he machine learning side of it was programmed abstractly so that this can be applied to any diseases that have these similar clinical outcome scale measurements,鈥� Lerman says. These could include Huntington鈥檚 and other neurodegenerative diseases.

In the future, they envision a prognostic tool and interface that a clinician could use when interacting with patients.

鈥淥ur hope for the next step is that when a patient goes to his or her doctor and asks, 鈥榃hat can I expect from this disease?鈥� the doctor can easily run the program to create an estimated timeline of the patient鈥檚 disease,鈥� Lerman says.